TY - JOUR
T1 - Movement disorders - Childhood Rating Scale 4-18 revised in children with dyskinetic cerebral palsy.
AU - Romeo, Domenico Marco
AU - Lucibello, Simona
AU - Battini, Roberta
AU - Sgandurra, Giuseppina
AU - Menici, Valentina
AU - Scalise, Roberta
AU - Olivieri, Ilaria
AU - Di Pietro, Roberta
AU - Giannini, Maria T.
AU - Cioni, Giovanni
AU - Leuzzi, Vincenzo
PY - 2020
Y1 - 2020
N2 - BACKGROUND:
Movement Disorders - Childhood Rating Scale 4-18 (MD-CRS 4-18) is a tool aimed to evaluate movement disorders in developmental age, validated since 2008 and applied in literature. Psychometric properties, including inter- and intra-reliability and construct validity have been evaluated over time on children and adolescents with different types of movement disorders.
AIM:
Aim of the study is to revise the Movement Disorders - Childhood Rating Scale 4-18 (MD-CRS 4-18 R) and evaluate its psychometric properties, compared to previous version of the scale, in Dyskinetic Cerebral palsy.
DESIGN:
This is a measurement-focused study of video recorder sessions.
SETTING:
Video session carried out inpatient and outpatient.
POPULATION:
This measurement-focused study was carried out on a cohort of 57 participants with DCP (37 males; mean age 9y 6mo, SD 3y 8mo) evaluated through video-recorded sessions by experienced scorers using MD-CRS 4-18 and MR-CRS 4-18 R.
METHODS:
Inter-rater reliability, intra-rater reliability of MD-CRS 4-18 and MD-CRS 4-18 R were performed.
RESULTS:
This study supports the relevant contribution of MD-CRS 4-18 R to identify the severity of movement disorders in dyskinetic cerebral palsy, as indicated by the higher ICC values on Index II compared to previous MD-CRS 4-18 results. Standard Error Measurement (SEM) and Minimally Detectable Difference (MDD) of MD-CRS 4-18 R in DCP were all very low, with SEMs ranging from 0.01 to 0.02 and MDD from 0.03 to 0.06.
CONCLUSIONS:
Data obtained with MD-CRS 4-18 R are in accordance with previous scale on individuals with movement disorders due to different aetiologies, tested with MD-CRS 4-18.
CLINICAL REHABILITATION IMPACT:
MD-CRS 4-18 R is able to verify natural history of the disease and represents a standardized clinical outcome measure in the evaluation and follow-up of children with DCP. Also MD-CRS 4-18 Revised form is a feasible tool, now easier to understand than the previous one, more available for incoming clinical trials.
AB - BACKGROUND:
Movement Disorders - Childhood Rating Scale 4-18 (MD-CRS 4-18) is a tool aimed to evaluate movement disorders in developmental age, validated since 2008 and applied in literature. Psychometric properties, including inter- and intra-reliability and construct validity have been evaluated over time on children and adolescents with different types of movement disorders.
AIM:
Aim of the study is to revise the Movement Disorders - Childhood Rating Scale 4-18 (MD-CRS 4-18 R) and evaluate its psychometric properties, compared to previous version of the scale, in Dyskinetic Cerebral palsy.
DESIGN:
This is a measurement-focused study of video recorder sessions.
SETTING:
Video session carried out inpatient and outpatient.
POPULATION:
This measurement-focused study was carried out on a cohort of 57 participants with DCP (37 males; mean age 9y 6mo, SD 3y 8mo) evaluated through video-recorded sessions by experienced scorers using MD-CRS 4-18 and MR-CRS 4-18 R.
METHODS:
Inter-rater reliability, intra-rater reliability of MD-CRS 4-18 and MD-CRS 4-18 R were performed.
RESULTS:
This study supports the relevant contribution of MD-CRS 4-18 R to identify the severity of movement disorders in dyskinetic cerebral palsy, as indicated by the higher ICC values on Index II compared to previous MD-CRS 4-18 results. Standard Error Measurement (SEM) and Minimally Detectable Difference (MDD) of MD-CRS 4-18 R in DCP were all very low, with SEMs ranging from 0.01 to 0.02 and MDD from 0.03 to 0.06.
CONCLUSIONS:
Data obtained with MD-CRS 4-18 R are in accordance with previous scale on individuals with movement disorders due to different aetiologies, tested with MD-CRS 4-18.
CLINICAL REHABILITATION IMPACT:
MD-CRS 4-18 R is able to verify natural history of the disease and represents a standardized clinical outcome measure in the evaluation and follow-up of children with DCP. Also MD-CRS 4-18 Revised form is a feasible tool, now easier to understand than the previous one, more available for incoming clinical trials.
KW - movement disorder
KW - movement disorder
UR - http://hdl.handle.net/10807/151829
U2 - 10.23736/S1973-9087.20.06079-7
DO - 10.23736/S1973-9087.20.06079-7
M3 - Article
SP - N/A-N/A
JO - European Journal of Physical and Rehabilitation Medicine
JF - European Journal of Physical and Rehabilitation Medicine
SN - 1973-9087
ER -